Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
Standard chemotherapy for women with advanced or recurrent cervical cancer involves a combination of paclitaxel, platinum, and bevacizumab. However, for patients who experience anaphylaxis in response to paclitaxel or platinum, have permanent peripheral neuropathy, or develop early recurrence or pro...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018-05-01
|
| シリーズ: | Gynecologic Oncology Reports |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2352578918300250 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|